Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection

Journal of Clinical Microbiology

Volumn 52, Issue 2, 2014, Pages 489-496

  Schroeder, Lee F ^a   Robilotti, Elizabeth ^a   Peterson, Lance R ^b   Banaei, Niaz ^a   Dowdy, David W ^c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; CYTOTOXICITY ASSAY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ECONOMIC EVALUATION; ENZYME IMMUNOASSAY; HOSPITAL COST; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TISSUE CULTURE;

ADULT; CLINICAL LABORATORY TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COST-BENEFIT ANALYSIS; CROSS INFECTION; DIARRHEA; HOSPITALS; HUMANS; IMMUNOASSAY; MOLECULAR DIAGNOSTIC TECHNIQUES; SENSITIVITY AND SPECIFICITY;

EID: 84893038141     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02777-13     Document Type: Article

References (48)

1. Johnson S, Gerding DN. 1998. Clostridium difficile-associated diarrhea. Clin. Infect. Dis. 26:1027-10341027-1036. http://dx.doi.org/10.1086/520276.
2. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH, Society for Healthcare Epidemiology of America, Infectious Diseases Society of America. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect. Control Hosp. Epidemiol. 31:431-455. http://dx.doi.org/10.1086/651706.
3. Jarvis WR, Schlosser J, Jarvis AA, Chinn RY. 2009. National point prevalence of Clostridium difficile in US health care facility inpatients, 2008. Am. J. Infect. Control 37:263-270. http://dx.doi.org/10.1016/j.ajic.2009.01. 001.
4. Bassetti M, Villa G, Pecori D, Arzese A, Wilcox M. 2012. Epidemiology, diagnosis and treatment of Clostridium difficile infection. Expert Rev. Anti Infect. Ther. 10:1405-1423. http://dx.doi.org/10.1586/eri.12.135.
5. Ghantoji SS, Sail K, Lairson DR, DuPont HL, Garey KW. 2010. Economic healthcare costs of Clostridium difficile infection: a systematic review. J. Hosp. Infect. 74:309-318. http://dx.doi.org/10.1016/j.jhin.2009.10.016.
6. Dubberke ER, Wertheimer AI. 2009. Review of current literature on the economic burden of Clostridium difficile infection. Infect. Control Hosp. Epidemiol. 30:57-66. http://dx.doi.org/10.1086/592981.
7. McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, Ufberg P, Muder RR, Lee BY. 2012. The economic burden of Clostridium difficile. Clin. Microbiol. Infect. 18:282-289. http://dx.doi.org/10.1111/j.1469-0691.2011.03571.x.
8. Zimlichman E, Henderson D, Tamir O, Franz C, Song P, Yamin CK, Keohane C, Denham CR, Bates DW. 2013. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system. JAMA Intern. Med. 173:2039-2046. http://dx.doi.org/10.1001/jamainternmed.2013.9763.
9. Kyne L, Hamel MB, Polavaram R, Kelly CP. 2002. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin. Infect. Dis. 34:346-353. http://dx.doi.org/10.1086/338260.
10. Peterson LR, Robicsek A. 2009. Does my patient have Clostridium difficile infection? Ann. Intern. Med. 151:176-179. http://dx.doi.org/10.7326/0003-4819- 151-3-200908040-00005.
11. Tenover FC, Novak-Weekley S, Woods CW, Peterson LR, Davis T, Schreckenberger P, Fang FC, Dascal A, Gerding DN, Nomura JH, Goering RV, Akerlund T, Weissfeld AS, Baron EJ, Wong E, Marlowe EM, Whitmore J, Persing DH. 2010. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J. Clin. Microbiol. 48:3719-3724. http://dx.doi.org/10.1128/JCM.00427-10.
12. Reyes RC, John MA, Ayotte DL, Covacich A, Milburn S, Hussain Z. 2007. Performance of TechLab C. DIFF QUIK CHEK and TechLab. C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples. Diagn. Microbiol. Infect. Dis. 59:33-37. http://dx.doi.org/10.1128/JCM.42.10.4863-4865.2004.
13. Burnham CA, Carroll KC. 2013. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin. Microbiol. Rev. 26:604-630. http://dx.doi.org/10.1128/CMR.00016-13.
14. Dubberke ER, Reske KA, Olsen MA, McDonald LC, Fraser VJ. 2008. Short-and long-term attributable costs of Clostridium difficile-associated disease in nonsurgical inpatients. Clin. Infect. Dis. 46:497-504. http://dx.doi.org/10. 1086/526530.
15. Kofsky P, Rosen L, Reed J, Tolmie M, Ufberg D. 1991. Clostridium difficile-a common and costly colitis. Dis. Colon Rectum 34:244-248. http://dx.doi.org/10.1007/BF02090164.
16. McFarland LV, Surawicz CM, Rubin M, Fekety R, Elmer GW, Greenberg RN. 1999. Recurrent Clostridium difficile disease: epidemiology and clinical characteristics. Infect. Control Hosp. Epidemiol. 20:43-50. http://dx.doi.org/ 10.1086/501553.
17. O'Brien JA, Lahue BJ, Caro JJ, Davidson DM. 2007. The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infect. Control Hosp. Epidemiol. 28:1219-1227. http://dx.doi.org/10.1086/522676.
18. Teasley DG, Gerding DN, Olson MM, Peterson LR, Gebhard RL, Schwartz MJ, Lee JT, Jr. 1983. Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis. Lancet ii:1043-1046.
19. Larson AM, Fung AM, Fang FC. 2010. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J. Clin. Microbiol. 48:124-130. http://dx.doi.org/10.1128/JCM.00734- 09.
20. Quinn CD, Sefers SE, Babiker W, He Y, Alcabasa R, Stratton CW, Carroll KC, Tang YW. 2010. C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens. J. Clin. Microbiol. 48:603-605. http://dx.doi.org/10.1128/JCM.01614- 09.
21. Sharp SE, Ruden LO, Pohl JC, Hatcher PA, Jayne LM, Ivie WM. 2010. Evaluation of the C. Diff Quik Chek complete assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J. Clin. Microbiol. 48:2082-2086. http://dx.doi.org/10.1128/JCM.00129-10.
22. Vasoo S, Stevens J, Portillo L, Barza R, Schejbal D, Wu MM, Chancey C, Singh K. Cost-effectiveness of a modified two-step algorithm using a combined glutamate dehydrogenase/toxin enzyme immunoassay and real-time PCRfor the diagnosis of Clostridium difficile infection. J. Microbiol. Immunol. Infect., in press. http://dx.doi.org/10.1016/j.jmii.2012.07.008.
23. Peterson LR, Mehta MS, Patel PA, Hacek DM, Harazin M, Nagwekar PP, Thomson RB, Jr, Robicsek A. 2011. Laboratory testing for Clostridium difficile infection: light at the end of the tunnel. Am. J. Clin. Pathol. 136:372-380. http://dx.doi.org/10.1309/AJCPTP5XKRSNXVIL.
24. Barbut F, Braun M, Burghoffer B, Lalande V, Eckert C. 2009. Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J. Clin. Microbiol. 47:1276-1277. http://dx.doi.org/10.1128/JCM. 00309-09.
25. Barbut F, Monot M, Rousseau A, Cavelot S, Simon T, Burghoffer B, Lalande V, Tankovic J, Petit JC, Dupuy B, Eckert C. 2011. Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR. Eur. J. Clin. Microbiol. Infect. Dis. 30:1279-1285. http://dx.doi.org/10.1007/s10096-011-1224-z.
26. Swindells J, Brenwald N, Reading N, Oppenheim B. 2010. Evaluation of diagnostic tests for Clostridium difficile infection. J. Clin. Microbiol. 48: 606-608. http://dx.doi.org/10.1128/JCM.01579-09.
27. Tenover FC, Baron EJ, Peterson LR, Persing DH. 2011. Laboratory diagnosis of Clostridium difficile infection: can molecular amplification methods move us out of uncertainty? J. Mol. Diagn. 13:573-582. http://dx.doi.org/10.1016/j. jmoldx.2011.06.001.
28. Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM. 2005. Case-control and two-gate designs in diagnostic accuracy studies. Clin. Chem. 51:1335-1341. http://dx.doi.org/10.1373/clinchem.2005.048595.
29. Rutjes AW, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PM. 2006. Evidence of bias and variation in diagnostic accuracy studies. CMAJ 174:469-476. http://dx.doi.org/10.1503/cmaj.050090.
30. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. 2011. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann. Intern. Med. 155: 529-536. http://dx.doi.org/10.7326/0003-4819-155-8-201110180-00009.
31. Dubberke ER, Han Z, Bobo L, Hink T, Lawrence B, Copper S, Hoppe-Bauer J, Burnham C-AD, Dunne WM, Jr. 2011. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J. Clin. Microbiol. 49:2887-2893. http://dx.doi.org/10.1128/JCM.00891-11.
32. Mower WR. 1999. Evaluating bias and variability in diagnostic test reports. Ann. Emerg. Med. 33:85-91. http://dx.doi.org/10.1016/S0196-0644(99) 70422-1.
33. Lanzas C, Dubberke ER, Lu Z, Reske KA, Gröhn YT. 2011. Epidemiological model for Clostridium difficile transmission in healthcare settings. Infect. Control Hosp. Epidemiol. 32:553-561. http://dx.doi.org/10. 1086/660013.
34. Jernigan JA, Titus MG, Gröschel DH, Getchell-White S, Farr BM. 1996. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am. J. Epidemiol. 143:496-504. http://dx.doi.org/10.1093/oxfordjournals.aje.a008770.
35. Luo RF, Banaei N. 2010. Is repeat PCR needed for diagnosis of Clostridium difficile infection? J. Clin. Microbiol. 48:3738-3741. http://dx.doi.org/10. 1128/JCM.00722-10.
36. Aichinger E, Schleck CD, Harmsen WS, Nyre LM, Patel R. 2008. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J. Clin. Microbiol. 46:3795-3797. http://dx.doi.org/10.1128/JCM.00684-08.
37. Bruins MJ, Verbeek E, Wallinga JA, Bruijnesteijn van Coppenraet LES, Kuijper EJ, Bloembergen P. 2012. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection. Eur. J. Clin. Microbiol. Infect. Dis. 31:3035-3039. http://dx.doi.org/10.1007/s10096-012-1658-y.
38. Culbreath K, Ager E, Nemeyer RJ, Kerr A, Gilligan PH. 2012. Evolution of testing algorithms at a university hospital for detection of Clostridium difficile infections. J. Clin. Microbiol. 50:3073-3076. http://dx.doi.org/10. 1128/JCM.00992-12.
39. Kawada M, Annaka M, Kato H, Shibasaki S, Hikosaka K, Mizuno H, Masuda Y, Inamatsu T. 2011. Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection. J. Infect. Chemother. 17:807-811. http://dx.doi.org/10. 1007/s10156-011-0267-5.
40. Orellana-Miguel MA, Alcolea-Medina A, Barrado-Blanco L, Rodriguez-Otero J, Chaves-Sánchez F. 2013. Algorithm proposal based on the C. Diff Quik Chek Complete ICT device for detecting Clostridium difficile infection. Enferm. Infecc. Microbiol. Clin. 31:97-99. http://dx.doi.org/10.1016/j.eimc.2012.01.003.
41. Goldenberg SD, Price NM, Tucker D, Wade P, French GL. 2011. Mandatory reporting and improvements in diagnosing Clostridium difficile infection: an incompatible dichotomy? J. Infect. 62:363-370. http://dx.doi.org/10.1016/j.jinf. 2011.03.007.
42. Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA, O'Connor L, Oakley SJ, Pope CF, Wren MW, Shetty NP, Crook DW, Wilcox MH. 2013. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study ofCdifficile infection. Lancet Infect. Dis. 13:17-20. http://dx.doi.org/10.1016/S1473-3099(12)70301-8.
43. Baker I, Leeming JP, Reynolds R, Ibrahim I, Darley E. 2013. Clinical relevance of a positive molecular test in the diagnosis of Clostridium difficile infection. J. Hosp. Infect. 84:311-315. http://dx.doi.org/10.1016/j.jhin.2013. 05.006.
44. Delmée M, Van Broeck J, Simon A, Janssens M, Avesani V. 2005. Laboratory diagnosis of Clostridium difficile-associated diarrhoea: a plea for culture. J. Med. Microbiol. 54:187-191. http://dx.doi.org/10.1099/jmm.0.45844-0.
45. Curry SR, Muto CA, Schlackman JL, Pasculle AW, Shutt KA, Marsh JW, Harrison LH. 2013. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin. Infect. Dis. 57:1094-1102. http://dx.doi.org/10. 1093/cid/cit475.
46. Guerrero DM, Becker JC, Eckstein EC, Kundrapu S, Deshpande A, Sethi AK, Donskey CJ. 2013. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients. J. Hosp. Infect. 85:155-158. http://dx.doi.org/10.1016/j. jhin.2013.07.002.
47. Leekha S, Aronhalt KC, Sloan LM, Patel R, Orenstein R. 2013. Asymptomatic Clostridium difficile colonization in a tertiary care hospital: admission prevalence and risk factors. Am. J. Infect. Control 41:390-393. http://dx.doi.org/10.1016/j.ajic.2012.09.023.
48. Walker AS, Eyre DW, Wyllie DH, Dingle KE, Harding RM, O'Connor L, Griffiths D, Vaughan A, Finney J, Wilcox MH, Crook DW, Peto TEA, Infections in Oxforshire Research Database. 2012. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med. 9:e1001172. http://dx.doi.org/10.1371/journal.pmed. 1001172.